Applied Biosystems is Odds-On Favourite at South Africa's National Horseracing Authority
News Nov 24, 2005
The National Horseracing Authority of Southern Africa (NHA) is using the Applied Biosystems / MDS Sciex Q TRAP LC/MS/MS System to screen racehorse urine and blood specimens for prohibited substances used to influence the outcome of races.
These substances include an ever-changing variety of drug entities and drug preparations, from small drug molecules to large protein hormones, all of which can differ significantly in their extraction and detection requirements.
Dr Schalk de Kock, Director of the laboratory, explained, "The Q TRAP System is an excellent technique for drug screening because of the complex sample matrices being analysed."
"It makes the extraction methodologies less time consuming and more cost effective, and is both sensitive and specific enough to accurately identify very low levels of substances."
"The design of the ionisation interface makes it possible to analyse specimens with a higher than conventional background, without deterioration in data quality or of the instrument."
"Another hugely advantageous feature is its ability to screen for large numbers of drugs in a single analysis, even when those drugs are closely related compounds."
"Overall, the Q TRAP System is a highly versatile instrument ideal for sensitive qualitative screening, qualitative and quantitative drug confirmation and research into new drug metabolism."
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE
Robust Multiplex Mass Spectrometric Assay for Screening Small-Molecule InhibitorsNews
A new original research article presents a fast, sensitive, and robust methodology for screening small molecule inhibitors against CD73/Ecto-5'-Nucleotidase, a promising target for developing anti-cancer drugs.READ MORE